ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Implementation of Minimally Invasive Esophagectomy From a Randomized Controlled Trial Setting to National Practice

Saturday, June 27, 2020

Submitted by

Mark Ferguson

Source

Source Name: Journal of Clinical Oncology

Source URL: https://ascopubs.org/doi/abs/10.1200/JCO.19.02483

Author(s)

Sheraz R. Markar, Melody Ni, Suzanne S. Gisbertz, Leonie van der Werf, Jennifer Straatman, Donald van der Peet, Miguel A. Cuesta, George B. Hanna, and Mark I. van Berge Henegouwen, on behalf of the Dutch Upper GI Cancer Audit and TIME Study Group

The previous randomized study of minimally invasive esophagectomy vs open esophagectomy (TIME trial) conducted in the Netherlands demonstrated reduced pulmonary complications and LOS with MIE. Compared to the benefits of MIE in those selected high volume centers, national use of MIE was associated with increased overall complications, increased pulmonary complications, and increased reoperation rates.